rs752007810
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.
The NM_000256.3(MYBPC3):c.2500C>T(p.Arg834Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000155 in 1,613,852 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R834Q) has been classified as Uncertain significance.
Frequency
Consequence
NM_000256.3 missense
Scores
Clinical Significance
Conservation
Publications
- hypertrophic cardiomyopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- hypertrophic cardiomyopathy 4Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
- left ventricular noncompaction 10Inheritance: AR, AD Classification: DEFINITIVE, MODERATE, LIMITED Submitted by: Ambry Genetics
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- arrhythmogenic right ventricular cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
- atrial fibrillationInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- dilated cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MYBPC3 | ENST00000545968.6 | c.2500C>T | p.Arg834Trp | missense_variant | Exon 25 of 35 | 5 | NM_000256.3 | ENSP00000442795.1 | ||
| MYBPC3 | ENST00000399249.6 | c.2500C>T | p.Arg834Trp | missense_variant | Exon 24 of 34 | 5 | ENSP00000382193.2 | |||
| MYBPC3 | ENST00000544791.1 | n.*5C>T | non_coding_transcript_exon_variant | Exon 25 of 27 | 5 | ENSP00000444259.1 | ||||
| MYBPC3 | ENST00000544791.1 | n.*5C>T | 3_prime_UTR_variant | Exon 25 of 27 | 5 | ENSP00000444259.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152200Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000120 AC: 3AN: 249090 AF XY: 0.00000740 show subpopulations
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1461652Hom.: 0 Cov.: 33 AF XY: 0.0000193 AC XY: 14AN XY: 727112 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152200Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74344 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Hypertrophic cardiomyopathy 4 Uncertain:2
- -
- -
Hypertrophic cardiomyopathy Uncertain:2
This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 834 of the MYBPC3 protein (p.Arg834Trp). This variant is present in population databases (rs752007810, gnomAD 0.003%). This missense change has been observed in individual(s) with sudden cardiac death and/or hypertrophic cardiomyopathy (PMID: 14563344, 34667957). ClinVar contains an entry for this variant (Variation ID: 454314). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
This missense variant replaces arginine with tryptophan at codon 834 of the MYBPC3 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with early-onset hypertrophic cardiomyopathy and sudden cardiac death, who also carried a pathogenic variant in the same gene (PMID: 14563344, 17908752), and in an individual who suffered sudden death (PMID: 27114410, 34667957, 34949102). This variant has been identified in 3/249090 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Cardiomyopathy Uncertain:1
This missense variant replaces arginine with tryptophan at codon 834 of the MYBPC3 protein. Computational prediction tools indicate that this variant has a neutral impact on protein structure and function. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in one individual affected with early-onset hypertrophic cardiomyopathy and sudden cardiac death, who also carried a pathogenic variant in the same gene (PMID: 14563344, 17908752), and in one individual affected with sudden death (PMID: 27114410, 34667957, 34949102). This variant has been identified in 3/249090 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
not provided Uncertain:1
- -
Cardiovascular phenotype Uncertain:1
The p.R834W variant (also known as c.2500C>T), located in coding exon 25 of the MYBPC3 gene, results from a C to T substitution at nucleotide position 2500. The arginine at codon 834 is replaced by tryptophan, an amino acid with dissimilar properties. This alteration has been reported in a sudden cardiac death subject, who also carried another missense alteration in MYBPC3 (Alders M et al. Eur Heart J, 2003 Oct;24:1848-53; Hofman N et al. Pediatrics, 2007 Oct;120:e967-73). This variant was also reported in another case of sudden cardiac death in a subject with a personal and family history of syncope (Anderson JH et al. Circ Cardiovasc Genet, 2016 Jun;9:259-65). This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at